Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01551745
Title Salvage Ovarian FANG Vaccine + Bevacizumab
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gradalis, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Mary Crowley Cancer Research Centers Dallas Texas 75230 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field